AAV-Mediated Gene Transfer Restores a Normal Muscle Transcriptome in a Canine Model of X-Linked Myotubular Myopathy
Open Access
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 28 (2) , 382-393
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institutes of Health
This publication has 53 references indexed in Scilit:
- Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse modelsDisease Models & Mechanisms, 2012
- Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotypeHuman Molecular Genetics, 2011
- Myotubularin Regulates Akt-dependent Survival Signaling via Phosphatidylinositol 3-PhosphateJournal of Biological Chemistry, 2011
- Inhibition of Activin Receptor Type IIB Increases Strength and Lifespan in Myotubularin-Deficient MiceThe American Journal of Pathology, 2011
- Dystrophin Immunity in Duchenne's Muscular DystrophyNew England Journal of Medicine, 2010
- MTM1 mutation associated with X-linked myotubular myopathy in Labrador RetrieversProceedings of the National Academy of Sciences, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphataseProceedings of the National Academy of Sciences, 2009
- AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasisHuman Molecular Genetics, 2008
- A gene mutated in X–linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeastNature Genetics, 1996